Proton Adaptive Therapy (PATh)
Today only 1% of Radiation Therapy (RT) patients have access to Proton Therapy (PT) while studies estimate that more than 20% of them could benefit from proton therapy.
Proton Adaptive Therapy (PATh) will be key in giving PT access to those 20% of RT patients.
Leading the PATh is an open collaborative platform to improve cancer treatment. In PATh, you share experiences, develop best practices and sharpen your knowledge of both PT methods and tools, all with the aim of improving cancer treatment and patient care.
If you believe in Together, Faster & Smarter open innovation, join PATh!